FB-101 treatment significantly reduced the expression of TGF-β1 mRNA (Fig. 5b, f), protein, and level of phospho-SMAD3 (Fig. 5d, h) in IPF mouse lung tissue compared to the control group. This evidence concerns the gene SMAD3 and idiopathic pulmonary fibrosis.